Preview

Pediatric pharmacology

Advanced search

MAGNETIC RESONANCE IMAGING IN DIAGNOSING FIBROTIC AND CICATRICIAL HEART ALTERATIONS IN CHILDREN

https://doi.org/10.15690/pf.v11i2.962

Abstract

The article provides an analysis of capabilities of magnetic resonance imaging with delayed contrast enhancement in diagnosing fibrotic alterations of varying severity. A hyperintense signal in the setting of myocardial delayed contrast enhancement programs indicates alterations of myocardial structure. Localization, severity and hyperintense signal size facilitate correct diagnosis and prognosis of complications development.

 

About the Authors

L. S. Namazova-Baranova
Scientific Center of Children’s Health, Moscow, Russian Federation Sechenov First Moscow State Medical University, Russian Federation Pirogov Russian National Medical Research University, Moscow
Russian Federation


V. I. Barskiy
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


V. E. Sinitsyn
Treatment and Rehabilitation Center of the Federal Service on Surveillance in Healthcare, Moscow, Russian Federation
Russian Federation


E. N. Basargina
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


A. N. Getman
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


A. B. Sugak
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


I. V. Silnova
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


E. N. Arkhipova
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


A. K. Gevorkyan
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation


References

1. Desjardins B., Crawford T., Good E., Oral H., Chugh A., Pelosi F., Morady F., Bogun F. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with post-infarction ventricular arrhythmia. Author manuscript; available in PMC 2010 May 1. Heart Rhythm. 2009 May; 6(5): 644–651.

2. Nathan M., Ying L. C., Pierre C., David B., Joao L. Assessment of myocardial fibrosis with cardiac magnetic resonance. Author manuscript; available in PMC 2012 February 22. J. Am. Coll. Cardiol. 2011 Feb. 22; 57(8): 891–903.

3. Florian A., Jurcut R., Ginghina C., Bogaert J. Cardiac Magnetic Resonance Imaging in Ischemic Heart Disease: A Clinical Review. J. Med. Life. 2011 Nov. 14; 4(4): 330–345. Published online 2011 Nov. 24.

4. Edelman R., Hesselink J., Zlatkin M. Clinical magnetic resonance imaging. 3rd Ed. Philadelphia, W.B. Saunders Co, 2004.

5. Parsai C., O’Hanlon R., Prasad S. K., Mohiaddin R. H. Diagnostic and prognostic value of cardiovascular magnetic resonance in nonischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012; 14(1): 54. Published online 2012 Aug. 2.

6. Adabag A. S., Maron B. J., Appelbaum E. et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 2008; 51: 1369–1374.

7. O'Hanlon R., Grasso A., Roughton M., Moon J. C., Clark S., Wage R., Webb J., Kulkarni M., Dawson D., Sulaibeekh L., Chandrasekaran B., Bucciarelli-Ducci C., Pasquale F., Cowie M. R., McKenna W. J., Sheppard M. N., Elliott P. M., Pennell D. J., Prasad S. K. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2010 Sep. 7; 56(11): 867–874.

8. Bruder O., Wagner A., Jensen C. J., Schneider S., Ong P., Kispert E. M., Nassenstein K., Schlosser T., Sabin G. V., Sechtem U., Mahrholdt H. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2010 Sep. 7; 56 (11): 875–887.


Review

For citations:


Namazova-Baranova L.S., Barskiy V.I., Sinitsyn V.E., Basargina E.N., Getman A.N., Sugak A.B., Silnova I.V., Arkhipova E.N., Gevorkyan A.K. MAGNETIC RESONANCE IMAGING IN DIAGNOSING FIBROTIC AND CICATRICIAL HEART ALTERATIONS IN CHILDREN. Pediatric pharmacology. 2014;11(2):78-80. https://doi.org/10.15690/pf.v11i2.962

Views: 729


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)